首页 › 基金 › Defilade Capital Management, L.P. › MREO

Defilade Capital Management, L.P. 对 MREO 的持仓历史

MEREO BIOPHARMA GROUP PLC · 医疗保健

Defilade Capital Management, L.P. 在 Q3 2026 的 13F 申报中披露持有 MREO(MEREO BIOPHARMA GROUP PLC)7,558,756 股,市值约 US$3.0M,约占其申报组合的 0.51%,在其申报持仓中市值排名第 30 位。 Defilade Capital Management, L.P. 最近 3 个申报季度中有 3 个季度披露了 MREO 持仓,最早可追溯至 Q1 2026。

最新持仓 (Q3 2026)7.56M 股
申报持仓市值$3.04M
组合权重0.51%
首次申报Q1 2026
最近变动持有
更新于2026-11-17

最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR

Defilade Capital Management, L.P. 对 MREO 的持仓演变

Defilade Capital Management, L.P. 于 Q1 2026 首次披露 MREO 持仓:7,558,756 股(约 US$2.5M)。 该持仓在 Q3 2026 达到峰值 7,558,756 股,市值约 US$3.0M。 在 3 次申报中,Defilade Capital Management, L.P. 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 7,558,756 股、市值约 US$3.0M。

逐季持仓明细

季度股数金额变化
Q1 2026 7.56M $2.49M 新进
Q2 2026 7.56M $2.40M 持有
Q3 2026 7.56M $3.04M 持有

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 MREO 与 13F 数据

MREO(MEREO BIOPHARMA GROUP PLC)属于医疗保健行业。我们追踪的基金中还有 4 只申报持有 MREO,申报仓位最大的包括:Tejara Capital Ltd (US$810K)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 MREO 的基金

查看 MREO 的全部基金持有人 →

常见问题

How long has Defilade Capital Management, L.P. held MREO?

Defilade Capital Management, L.P. has disclosed MREO holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Defilade Capital Management, L.P.'s current position in MREO?

As of Q3 2026, Defilade Capital Management, L.P. holds 7.56M shares of MREO (MEREO BIOPHARMA GROUP PLC), valued at $3.04M, representing 0.51% of its reported portfolio and ranking #30.

Has Defilade Capital Management, L.P. been buying or selling MREO?

In the latest 13F filing (Q3 2026), Defilade Capital Management, L.P. held unchanged its position in MREO. The position peaked in Q3 2026 at 7.56M shares.

Which other funds hold MREO?

Other major institutional holders of MREO include Tejara Capital Ltd, among 4 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.